tiprankstipranks
Trending News
More News >
Ultragenyx Pharmaceutical (DE:UP0)
FRANKFURT:UP0
Advertisement

Ultragenyx Pharmaceutical (UP0) Revenue

Compare
2 Followers

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had a revenue of 159.93M in the quarter ending Sep 30, 2025, with -3.94%. This bring the company's revenue in the last twelve months to 630.60M, Decreased 3.35%. In the fiscal year ending Dec 31, 2024, Ultragenyx Pharmaceutical had annual revenue of 560.23M with 29.01% growth.
Revenue (ttm)
630.60M
Revenue Growth
P/S Ratio
4.56
Revenue/Employee
$432,944
Employees
1,294
Market Cap
$2.55B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
560.23M125.98M+129.01%
Dec 31, 2023
434.25M70.92M+119.52%
Dec 31, 2022
363.33M11.92M+103.39%
Dec 31, 2021
351.41M80.38M+129.66%
Dec 31, 2020
271.03M167.32M+261.32%
Dec 31, 2019
103.71M52.22M+201.41%
Dec 31, 2018
51.49M48.88M+1,971.48%
Dec 31, 2017
2.61M2.48M+1,963.92%
Dec 31, 2016
133.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis